Quantitative MRI Biomarkers as Potential Inclusion Body Myositis Clinical Trial Endpoints. Greenberg SA, Dmitrienko A, Hayes M. Neurology 2022;99:361-362.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Greenberg SA, Dmitrienko A, Hayes M. Quantitative MRI Biomarkers as Potential Inclusion Body Myositis Clinical Trial Endpoints. Neurology 2022;99:361-362.
PMID: 36038280